Brokerages Expect Marchex, Inc. (MCHX) Will Post Quarterly Sales of $22.57 Million

Analysts expect Marchex, Inc. (NASDAQ:MCHX) to announce $22.57 million in sales for the current quarter, according to Zacks Investment Research. Two analysts have issued estimates for Marchex’s earnings, with the highest sales estimate coming in at $22.60 million and the lowest estimate coming in at $22.54 million. Marchex posted sales of $21.85 million during the same quarter last year, which suggests a positive year over year growth rate of 3.3%. The business is expected to issue its next quarterly earnings report after the market closes on Wednesday, February 13th.

On average, analysts expect that Marchex will report full-year sales of $84.68 million for the current financial year, with estimates ranging from $84.66 million to $84.70 million. For the next year, analysts anticipate that the business will report sales of $100.40 million, with estimates ranging from $97.50 million to $103.30 million. Zacks’ sales calculations are an average based on a survey of sell-side analysts that follow Marchex.

MCHX has been the topic of several research reports. TheStreet upgraded Marchex from a “d+” rating to a “c-” rating in a research note on Wednesday, January 30th. Zacks Investment Research lowered Marchex from a “buy” rating to a “hold” rating in a research note on Tuesday, January 29th. Finally, Roth Capital upgraded Marchex from a “neutral” rating to a “buy” rating and upped their target price for the stock from $3.40 to $7.00 in a research note on Monday, January 28th.

MCHX stock traded up $0.25 during midday trading on Wednesday, hitting $4.49. The company’s stock had a trading volume of 755,878 shares, compared to its average volume of 232,264. Marchex has a 1 year low of $2.47 and a 1 year high of $4.75. The stock has a market cap of $178.00 million, a P/E ratio of -32.07 and a beta of 1.67.

In other Marchex news, major shareholder Edenbrook Capital, Llc bought 63,059 shares of the firm’s stock in a transaction on Thursday, December 20th. The shares were acquired at an average cost of $2.68 per share, for a total transaction of $168,998.12. The acquisition was disclosed in a filing with the SEC, which can be accessed through this hyperlink. 22.49% of the stock is owned by corporate insiders.

Several institutional investors and hedge funds have recently bought and sold shares of the company. We Are One Seven LLC boosted its holdings in shares of Marchex by 20.2% in the 4th quarter. We Are One Seven LLC now owns 19,400 shares of the technology company’s stock worth $51,000 after purchasing an additional 3,260 shares in the last quarter. Algert Global LLC purchased a new stake in Marchex during the 4th quarter valued at about $29,000. FNY Investment Advisers LLC purchased a new stake in Marchex during the 4th quarter valued at about $42,000. BlackRock Inc. boosted its holdings in Marchex by 3.6% during the 2nd quarter. BlackRock Inc. now owns 794,348 shares of the technology company’s stock valued at $2,430,000 after acquiring an additional 27,930 shares during the period. Finally, Cpwm LLC boosted its holdings in Marchex by 15.0% during the 3rd quarter. Cpwm LLC now owns 260,860 shares of the technology company’s stock valued at $725,000 after acquiring an additional 34,013 shares during the period. Hedge funds and other institutional investors own 49.40% of the company’s stock.

Marchex Company Profile

Marchex, Inc is a call analytics company, which engages in connecting online behavior to real-world and offline actions. The company offers driving phone calls and local leads platform through the Call-Driven segment. Its products include call, search, and display and video analytics. The company was founded by Russell C.

Recommended Story: What are municipal bonds?

Get a free copy of the Zacks research report on Marchex (MCHX)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Receive News & Ratings for Marchex Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Marchex and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply